Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Herlev Hospital
SCRI Development Innovations, LLC
Herlev Hospital
University of Wisconsin, Madison
University of California, Davis
M.D. Anderson Cancer Center
Hoosier Cancer Research Network
Fudan University
University of Southern California
Emory University
Seoul National University Hospital
Fudan University
Korean Breast Cancer Study Group
Hoosier Cancer Research Network
American University of Beirut Medical Center